Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

NORML

MAY 24, 2019

Governor Jared Polis (D) of Colorado signed legislation into law that allows physicians to recommend medical cannabis for any condition for which an opiate would otherwise be prescribed. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

Legislation 192

Legislation Hemp Access Patients 192

The Cannigma

MARCH 26, 2021

Last April 7th, 13-year-old Charlotte Figi, whose battle with a rare, catastrophic form of early childhood epilepsy called Dravet syndrome raised awareness for medical cannabis across the world, died of cardiac arrest and respiratory failure brought on by a seizure. I never thought that I would see cannabis become an essential business.

Epilepsy 120

Epilepsy Wellness and Beauty Treatment Cannabis 120

MJ Business Attorneys

OCTOBER 26, 2017

She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. In 2014, I was reading the Senate Bill 339 [Texas’ Compassionate Use Act enacted in 2015] testimony of mothers of children with epilepsy. Based on what I read on epilepsy I knew it had some success there.

Epilepsy 100

Epilepsy Recreational Treatment Programs 100

MGC Pharma

DECEMBER 12, 2017

Fortunately, at MGC Pharma, we are in the business of Medical Cannabis and have spent years researching and understanding the effects and phenotypes of different strains to determine which ones work best for different conditions, with each containing different amounts of THC, CBD and other components. You can learn more about it here.

Epilepsy 100

Epilepsy Pharmaceutical Cannabinoids THC 100

Otherside Farms

DECEMBER 21, 2019

Are you considering getting into the growing and/or selling business and want to know how to promote your products to your customers? This includes chronic muscle or joint pain associated with conditions like arthritis and fibromyalgia. Throughout the U.S., Have you been wondering whether marijuana could be beneficial to you?

Digestion 96

Digestion Marijuana Indica Epilepsy 96

The Cannigma

APRIL 5, 2021

The state still needs to staff the Office of Cannabis Management and the Cannabis Control Board, finalize the regulations for cannabis sellers, producters, and growers, and approve licenses for cannabis businesses. Not every city or town will necessarily have dispensaries or consumption lounges. The good news?

Legalization 137

Legalization Consumption Dispensary Vaping 137

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

WeedAdvisor

JULY 15, 2019

Over a million Ohio citizens could see their medical options open if the state decides to expand its eligible medical marijuana conditions, reports The Center Square. Evidence for marijuana’s efficacy against autism and anxiety are not as rock solid as CBD and epilepsy – the only use of cannabis approved by the FDA.

Conditions 45

Conditions Marijuana Patients Epilepsy 45

Cannabis Law Report

AUGUST 12, 2022

As Hong Kong takes its first steps toward cracking down on cannabidiol, businesses specializing in CBD-infused beers, coffees and other products are scrambling to work out what comes next. which owns Found and supplies CBD products to other businesses in the city. For CBD-focused businesses, that may spell the beginning of the end.

CBD 98

CBD THC Epilepsy Sleep 98

CannaTech

JUNE 30, 2019

There are two main sections to the reform, one for businesses and the second for patients: Reform to cannabis business licensing process: The licensing process for cannabis research institutes and cannabis dispensing pharmacies expanded and clarified. This permit encompasses business planning and development pending final approval.

Patients 90

Patients Oil Epilepsy Strains 90

Veriheal

AUGUST 25, 2021

The state recently awarded cultivation licenses to six growers, all of whom are expected to launch their businesses in the next few months. Once the bill was effectuated in July 2018, more qualifying conditions were added to the list of criteria for eligible patients. About Georgia’s Medical Cannabis Law.

Cultivation 98

Cultivation Oil THC Patients 98

Veriheal

OCTOBER 30, 2023

Additionally, research, testing, and manufacturing licenses are reserved for businesses that are at least 30% Bahamian-owned. They will now be allowed to prescribe medical cannabis to treat conditions like depression, epilepsy, multiple sclerosis, post-traumatic stress disorder , and cancer.

Legalization 119

Legalization Therapy Decriminalization Epilepsy 119

Cannabis Law Report

DECEMBER 9, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TXOG), Texas’ leading medical cannabis provider, celebrates 4-year-old Carter Halliburton’s success story as he recognizes the benefits of TXOG’s medicine in navigating his rare neurological conditions.

Conditions 40

Conditions Patients Sleep Medicine 40

Cannabis Law Report

SEPTEMBER 9, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

SpeedWeed

MARCH 30, 2021

Business Cann first reported on the development of the ‘Patient Registry for Cannabis-Based Products’, last year and the NHS has confirmed it will launch on April 1. ( He would like to see the registry opened up to the private sector and believes the restricted conditions available for treatment through the NHS will limit its effectiveness.

Data 52

Data Patients Clinical Trials Business 52

MassRoots

MARCH 14, 2019

It’ll open up the choices patients have available to them and they can purchase their medical marijuana to treat their condition,” said Executive Vice President of Grow Ohio Justin Hunt. “We Only four retail locations were open for business on the first day that sales began. 9 Dispensaries are open for business.

Edibles 80

Edibles Patients Tincture Programs 80

Cannabis Law Report

JULY 9, 2021

One of the most popular uses for CBD products is to relieve aches and pains caused by aging, injuries, or medical conditions. Usually, mental health conditions are treated using pharmaceutical drugs, although they can result in side effects such as agitation, drowsiness, headaches, and insomnia. Pain Relief. Promoting a Healthy Heart.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy (the Violet Study). Marinus investor event: Marinus Pharmaceutical Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

CannaTech

APRIL 1, 2020

Hundreds of thousands of patients around the world rely on cannabis medicine to treat a range of conditions, including epilepsy, Parkinsons, cancer, PTSD, Crohn’s disease, autism, chronic pain and more. I am pleased to read that cannabis dispensaries are being classified as essential businesses in the U.S.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

Cannabis Law Report

AUGUST 19, 2021

“Most importantly, there is no definitive evidence as yet that CBD would work for any of the myriad health conditions which it is supposed to benefit, except for certain types of epilepsy.” ” [link]. . ” [link].

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

CannaEffect

JULY 7, 2017

Harper Howard’s family never saw her smile until age 3, when they administered hemp oil to treat the life-threatening genetic disorder CDKL5 epilepsy. Beyla was born with hydrocephalus , a condition that causes excessive fluid in the brain. Caracciolo told Cannabis Talk 101, “It brought her back to life.

Business 57

Business Oil Hemp Epilepsy 57

Veriheal

NOVEMBER 10, 2020

The list of qualifying conditions in which physicians will use a guide for those who may be prescribed medical cannabis in the experiment. . The procedures for importing, storing, distributing, and controlling medical cannabis. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Dykema (Cannabis Law Blog)

APRIL 20, 2023

[iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Specifically, H.B. Specifically, H.B.

Law 74

Law Chronic Pain Conditions Medicine 74

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Veriheal

MARCH 6, 2024

The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain. The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety.

Research and Development 64

Research and Development DEA Chronic Pain Business 64

Veriheal

DECEMBER 28, 2021

Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S. Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

MARCH 24, 2020

The letter notes the importance of declaring all cannabis businesses “essential,” as most adult-use consumers are using cannabis for therapeutic purposes.This includes many veterans due to a Veterans Affairs policy against VA physicians providing medical cannabis certifications. The Epilepsy Foundation signed onto the medical letter.

Law 53

Law Epilepsy Treatment Access 53

Cannabis Law Report

SEPTEMBER 1, 2021

After the legalization of cannabis in Canada , small businesses have attained success in the country. . Patients in the UK who are suffering from epilepsy, multiple sclerosis, insomnia, chronic pain, anxiety, and other medical conditions can use medical cannabis as an adjunct or alternative treatment. Conclusion.

Legalization 109

Legalization Marijuana Treatment Patients 109

Cannabis Law Report

SEPTEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions. billion by 2028, registering a CAGR of 26.3% Medical Use.

Recreational 73

Recreational Hemp THC Legalization 73

Veriheal

JULY 26, 2023

The General Assembly finds that thousands of Georgians have serious medical conditions that can be improved by the medically approved use of cannabis and that the law should not stand between them and treatment necessary for life and health.”

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

MARCH 29, 2019

However, the Lone Star State could make significant progress toward expanding the Compassionate Use Program and putting medical treatment choices for certain medical conditions into the hands of medical providers and patients rather than politicians. Currently, only epilepsy patients may use the drug produced at three state facilities.

Epilepsy 45

Epilepsy Law Chronic Pain Programs 45

Veriheal

JANUARY 12, 2023

Planting cannabis for personal consumption or business remains illegal under French law, which applies in French Polynesia. . Approximately 3,000 patients who suffer from debilitating conditions like chronic pain and epilepsy will partake in the project, which is due to end in March 2023.

Medicine 97

Medicine Chronic Pain Consumption Cannabis 97

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Conference call and webcast to be held today at 4:30 p.m. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

MMJ Recs

JUNE 3, 2024

The amendment allowed patients with qualifying conditions to access medical cannabis under the supervision of licensed physicians. As Missouri’s medical marijuana program matured, the number of licensed businesses and registered patients continued to grow. Guardians or parents can apply on behalf of minors in need of treatment.

Programs 52

Programs Marijuana Patients Chronic Pain 52

Veriheal

JULY 2, 2020

However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The Bill as Passed. The final approved bill was sent to Governor John Bel Edwards’ desk on June 1st.

Banking 52

Banking Programs Therapy Conditions 52